Physician profile

Vibha Sabharwal

Urology · Bolingbrook, IL

NPI 1235171943

$13,042.81

in general payments reported to CMS, 2019-2025

42 companies · $1,710 in 2025

The $1,710 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,987.87
Consulting Fee$500.00
Education$452.98
Travel and Lodging$429.66

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Axonics, INC. $3,707.83 2021-2024 Bulkamid, Axonics
Astellas Pharma US INC $1,355.62 2019-2025 Xtandi, Myrbetriq, Padcev
Sumitomo Pharma America, INC. $911.31 2023-2025 Gemtesa, Orgovyx
Urovant Sciences INC $831.96 2021-2022
Boston Scientific Corporation $762.49 2019-2025 Ams 700, Axonics, Ams 800 Artificial Urinary Sphincter
Coloplast Corp $615.96 2019-2023 Speedicath
Janssen Biotech, INC. $568.23 2019-2025 Erleada
Medivators INC. $500.00 2021
Olympus Winter & Ibe Gmbh $500.00 2025 Endoeye Flex Deflectable Videoscope
Antares Pharma, INC. $353.00 2020-2023 Nocdurna, Tlando, Xyosted
Pfizer INC. $311.10 2019
Bayer Healthcare Pharmaceuticals INC. $284.87 2019-2025
Laborie Medical Technologies Corp. $234.53 2021-2024 Urgent PC Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter
Procept Biorobotics Corporation $225.42 2021-2025
Olympus America INC. $200.96 2020-2025 Soltive, Itind System
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $165.36 2019-2022
Endo USA, INC. $165.27 2025 Xiaflex
Calyxo, INC. $162.22 2025 Cvac Aspiration System
Caldera Medical, INC $121.86 2019
Clarus Therapeutics INC. $90.59 2021
W. L. Gore & Associates, INC. $89.42 2021-2023 Gore Cardioform Septal Occluder
180 Medical, INC. $84.08 2021-2022
Abbvie INC. $80.26 2019-2024
Allergan, INC. $76.91 2019-2021
Astrazeneca Pharmaceuticals LP $70.58 2020-2021
Dendreon Pharmaceuticals LLC $63.75 2019-2021
Endo Pharmaceuticals INC. $56.31 2019
Ferring Pharmaceuticals INC. $56.18 2019
Myovant Sciences INC. $54.58 2021-2022
Telix Pharmaceuticals $52.99 2023-2025 Illuccix
Halozyme INC $46.14 2023
Merck Sharp & Dohme LLC $42.45 2020-2021
Myriad Genetic Laboratories, INC. $35.02 2021-2023 Myrisk
Novartis Pharmaceuticals Corporation $30.57 2025
Ambu INC. $20.52 2025
Acerus Pharmaceuticals Corporation $19.98 2020
Alnylam Pharmaceuticals INC. $19.58 2021
Tolmar Pharmaceuticals, INC. $17.11 2022
Tolmar, INC. $16.87 2024
Mission Pharmacal Company $14.19 2023 Uribel
Blue Earth Diagnostics $13.91 2019
Medtronic USA, INC. $12.83 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Vibha Sabharwal

$13,042.81

in general payments reported 2019-2025

Years
2019-2025
Top company
Axonics, INC.
Context
The $1,710 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/283296/vibha-sabharwal

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.